WILLINGNESS TO PAY FOR DOWN SYNDROME PRENATAL SCREENING OF PREGNANT WOMEN AT HANOI OBSTETRICS AND GYNECOLOGY HOSPITAL, 2020

Nguyễn Duy Ánh

Main Article Content

Abstract

Objective: To determine the rate and willingness to pay of pregnant women for Down syndrome prenatal screening at Hanoi Obstetrics and Gynecology Hospital in 2020. Method: Employing contigent valuation method with double-bounded question design to estimate willingness to pay for prenatal screening for Down syndrome with 223 pregnant women randomly selected from the list of patients visiting the Center for Prenatal Diagnosis and Newborn Screening at Hanoi Obstetrics and Gynecology Hospital from March to June, 2020. Results and conclusions: The results showed that 95% of pregnant women were willing to pay for combined screening, the average price for which pregnant women were willing to pay was VND 1,905,010. However, only 65% ​​of pregnant women were willing to pay for a non-invasive prenatal test, the average price for a pregnant woman willing to pay was VND 9,097,230.

Article Details

References

1. L.Venkatachalam, The contingent valuation method: a review. Institute for Social and Economic Change, 2003.
2. XiuruiGuo, H., Xianqiang Mao, Jianjun Jin, Dongsheng Chen, Shuiyuan Cheng, Willingness to pay for renewable electricity: A contingent valuation study in Beijing, China. Energy Policy, 2014. 68: p. 340-347.
3. Thanh, N.H., H.V. Minh, and N.V. Hùng, Âp dụng phương pháp định giá ngẫu nhiên phụ thuộc nghiên cứu sẵn sàng chi trả cho xây dựng hệ thống xử lý nước thải tại một vùng nông thôn Việt Nam. Tạp chí Nghiên cứu y học, 2012. 79(2): p. 151-157.
4. Wang, K., et al., Analysis of residents' willingness to pay to reduce air pollution to improve children's health in community and hospital settings in Shanghai, China. Science of The Total Environment, 2015. 533: p. 283-289.
5. Pei-JungLin, et al., Willingness to Pay for Diagnostic Technologies: A Review of the Contingent Valuation Literature. Value in Health, 2013. 16(5): p. 797-805.
6. Ilona M. Kopits, et al., Willingness to Pay for Genetic Testing for Alzheimer’s Disease: A Measure of Personal Utility. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011. 15: p. 871-875.
7. E.J.Verweij, et al., Non-invasive prenatal screening for trisomy 21: What women want and are willing to pay. PEC Journal, 2013. 93(3): p. 641-645.